BDB-001 Phase III Trial in ANCA-Associated Vasculitis

NCT07168161 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

ANCA Associated Vasculitis (AAV)

Interventions

DRUG: BDB-001 injection
DRUG: Cyclophosphamide
BIOLOGICAL: Rituximab
DRUG: Azathioprine
DRUG: Prednisone

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd